KR940018385A - 엘립티신 유도체 및 그의 제조방법 - Google Patents

엘립티신 유도체 및 그의 제조방법 Download PDF

Info

Publication number
KR940018385A
KR940018385A KR1019940001656A KR19940001656A KR940018385A KR 940018385 A KR940018385 A KR 940018385A KR 1019940001656 A KR1019940001656 A KR 1019940001656A KR 19940001656 A KR19940001656 A KR 19940001656A KR 940018385 A KR940018385 A KR 940018385A
Authority
KR
South Korea
Prior art keywords
group
substituted
protected
groups
unprotected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019940001656A
Other languages
English (en)
Korean (ko)
Inventor
겐지 스지하라
나오유끼 하라다
구니히꼬 오자끼
모또아끼 오하시
고지 오다
Original Assignee
지바따 이찌로
다나베세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지바따 이찌로, 다나베세이야꾸 가부시끼가이샤 filed Critical 지바따 이찌로
Publication of KR940018385A publication Critical patent/KR940018385A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019940001656A 1993-01-29 1994-01-29 엘립티신 유도체 및 그의 제조방법 Ceased KR940018385A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP93-13441 1993-01-29
JP1344193 1993-01-29

Publications (1)

Publication Number Publication Date
KR940018385A true KR940018385A (ko) 1994-08-16

Family

ID=11833224

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940001656A Ceased KR940018385A (ko) 1993-01-29 1994-01-29 엘립티신 유도체 및 그의 제조방법

Country Status (11)

Country Link
US (2) US5565569A (enExample)
EP (1) EP0608876A1 (enExample)
KR (1) KR940018385A (enExample)
CN (1) CN1042731C (enExample)
AU (1) AU666416B2 (enExample)
CA (1) CA2114468A1 (enExample)
FI (1) FI940403A7 (enExample)
IL (1) IL108461A (enExample)
MY (1) MY110683A (enExample)
SG (1) SG42916A1 (enExample)
TW (1) TW269688B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696465B1 (fr) * 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2757859B1 (fr) * 1996-12-30 1999-01-29 Adir Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2757858B1 (fr) * 1996-12-30 1999-01-29 Adir Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6512102B1 (en) 1998-12-31 2003-01-28 Chiron Corporation Compositions and methods of diagnosis and treatment using casein kinase I
US7847109B2 (en) * 2002-05-31 2010-12-07 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
PL1877098T3 (pl) * 2005-05-05 2013-09-30 Glaxosmithkline Ip Dev Ltd Koniugaty estru alfa-aminokwasu z lekiem ulegające hydrolizie z udziałem karboksyloesterazy
FR2925491B1 (fr) * 2007-12-19 2010-09-03 Oz Biosciences Sas Nouvelle classe de lipides cationiques pour le transport d'agents actifs dans les cellules
US20150119388A1 (en) * 2012-06-15 2015-04-30 The Children's Hospital Philadelphia Novel pro- and codrug derivatives for nanoparticle delivery of select anticancer agents formed using rapidly cleavable phenolic ester bridges

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933827A (en) * 1974-10-29 1976-01-20 Hoffmann-La Roche Inc. 9-Acyloxy-5,11-dimethyl-6H-pyrido[4,3-B]carbazoles
FR2308365A2 (fr) * 1975-04-25 1976-11-19 Anvar Derives de l'hydroxy-9 ellipticine et leur application therapeutique
US4310667A (en) * 1976-04-22 1982-01-12 Agence Nationale De Valorisation De La Recherche (Anvar) 2-N Quaternary ammonium salt derivatives of 9-hydroxy ellipticine
JPS6137799A (ja) * 1984-07-31 1986-02-22 Suntory Ltd エリプチシン誘導体およびその製造法
AU4245689A (en) * 1988-10-04 1990-04-12 Suntory Limited Ellipticine glycoside derivatives
JPH05310736A (ja) * 1992-05-06 1993-11-22 Tanabe Seiyaku Co Ltd エリプティシン誘導体、その製法およびその合成中間体
US5272146A (en) * 1992-10-02 1993-12-21 The United States Of America As Represented By The United States Department Of Health And Human Services 1,2-dihydroellipticines with activity against CNS specific cancer cell lines
FR2696465B1 (fr) * 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
US5565569A (en) 1996-10-15
CA2114468A1 (en) 1994-07-30
SG42916A1 (en) 1997-10-17
TW269688B (enExample) 1996-02-01
IL108461A (en) 1998-09-24
AU5394794A (en) 1994-08-04
CN1099034A (zh) 1995-02-22
MY110683A (en) 1999-01-30
US5605904A (en) 1997-02-25
FI940403L (fi) 1994-07-30
IL108461A0 (en) 1994-04-12
AU666416B2 (en) 1996-02-08
CN1042731C (zh) 1999-03-31
EP0608876A1 (en) 1994-08-03
FI940403A0 (fi) 1994-01-27
FI940403A7 (fi) 1994-07-30

Similar Documents

Publication Publication Date Title
AU699008B2 (en) Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
IE811566L (en) Steel articles protected against corrosion.
KR920018049A (ko) 이미다조피리딘
KR870006072A (ko) 라파마이신 전구체의 제조방법
KR950000728A (ko) 포스포네이트 뉴클레오티드 에스테르 유도체
CA2421114A1 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
KR830009118A (ko) 세펨화합물의 제조방법
KR910009712A (ko) 세펨 화합물 및 이의 제조방법
KR910000727A (ko) 5,11-디하이드로-6H-디피리도[3, 2-b : 2', 3'-e] [1, 4] 디아제핀-6-온 및-티온 및 AIDS의 예방 또는 치료를 위한 이의 용도
KR940018385A (ko) 엘립티신 유도체 및 그의 제조방법
CA2051356A1 (en) Antineoplastic modified imidazoacridines
WO1995016695A3 (en) 3'-aziridino-anthracycline derivatives
KR950014094A (ko) 에스큘레틴 유도체, 그의 제조 방법, 그의 용도 및 약학 조성물
RU1804462C (en) Method of cefem compounds or theirs salts synthesis
CA2019260A1 (en) Penam derivatives and salts thereof, processes for producing the same and antibacterial agent comprising the same
KR930023328A (ko) N-메틸데아세틸콜히세인아미드 유도체
DE69107431D1 (de) Deacetylcolchicinderivate.
KR890002174A (ko) 삼환성 세팜 화합물, 그의 제조방법 및 용도
EP0852231A3 (en) 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR920008050A (ko) 세펨 화합물, 이의 제조방법 및 항균제
EP0869115A3 (en) Amino acid derivatives and compositions containing the same for inhibiting active-oxygen
WO1999038858A8 (en) Benzo[b]pyran derivatives useful as external agents for the skin
KR910015585A (ko) 신규한 세팔로스포린 화합물과 그의 제조방법
KR910015586A (ko) 신규한 세팔로스포린 화합물과 그의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)